These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31038390)

  • 1. Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis.
    Kori M; Gov E; Arga KY
    OMICS; 2019 May; 23(5):261-273. PubMed ID: 31038390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
    Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
    Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.
    van Dam PA; van Dam PJ; Rolfo C; Giallombardo M; van Berckelaer C; Trinh XB; Altintas S; Huizing M; Papadimitriou K; Tjalma WA; van Laere S
    Oncotarget; 2016 Jan; 7(3):2780-95. PubMed ID: 26701206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
    Vaghasia H; Sakaria S; Prajapati J; Saraf M; Rawal RM
    Comput Biol Med; 2022 Oct; 149():105994. PubMed ID: 36103746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.
    Kori M; Yalcin Arga K
    PLoS One; 2018; 13(7):e0200717. PubMed ID: 30020984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Hub Genes Associated with Cervical Cancer through Gene Co-Expression Networks.
    Deng SP; Zhu L; Huang DS
    IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(1):27-35. PubMed ID: 26415208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
    Ayyildiz D; Gov E; Sinha R; Arga KY
    OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine.
    Kori M; Demirtas TY; Comertpay B; Arga KY; Sinha R; Gov E
    OMICS; 2024 Feb; 28(2):90-101. PubMed ID: 38320250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
    Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
    Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
    Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
    J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of
    Zhao S; Yu M
    DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
    Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
    Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
    Wang Q; Zhang L; Yan Z; Xie L; An Y; Li H; Han Y; Zhang G; Dong H; Zheng H; Zhu W; Li Y; Wang Y; Guo X
    Future Oncol; 2019 Nov; 15(32):3693-3699. PubMed ID: 31512935
    [No Abstract]   [Full Text] [Related]  

  • 16. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages.
    Fu Y; Zhou QZ; Zhang XL; Wang ZZ; Wang P
    Med Sci Monit; 2019 Nov; 25():8873-8890. PubMed ID: 31758680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.